Literature DB >> 19808497

Risk of failure of transvenous implantable cardioverter-defibrillator leads.

C Jan Willem Borleffs1, Lieselot van Erven, Rutger J van Bommel, Enno T van der Velde, Ernst E van der Wall, Jeroen J Bax, Frits R Rosendaal, Martin J Schalij.   

Abstract

BACKGROUND: Despite the positive effect on mortality in selected patients, implantable cardioverter-defibrillator therapy is also associated with potential malfunction of the implanted system. The present study provides the long-term lead failure rate in a large single-center cohort. METHODS AND
RESULTS: Since 1992, a total of 2068 implantable cardioverter-defibrillator patients with 2161 defibrillation leads were prospectively collected. Data of the implant procedure and all follow-up visits were recorded. All cases of lead removal or capping or placing of an additional pace or sense lead were noted and analyzed. Lead models were grouped by manufacturer and approximate lead diameter in French. During a mean follow-up of 36 months, 82 (3.8%) cases of lead failure were identified. Cumulative incidence of lead failure at 1 year was 0.6%; at 5 years, 6.5%; and at 10 years, 16.4%. The highest risk of lead failure was found in small-diameter leads. Adjusted hazard ratio was 6.4 (95% CI, 3.2 to 12.8) for Medtronic 7F leads, when compared with all other leads.
CONCLUSIONS: In this large single-center experience, the overall incidence of lead failure was 1.3 (95% CI, 1.0 to 1.6) per 100 lead-years. Comparison of different groups of leads shows major differences in event rates. Specific manufacturer's small-diameter defibrillation leads may have a higher risk of early lead failure.

Entities:  

Mesh:

Year:  2009        PMID: 19808497     DOI: 10.1161/CIRCEP.108.834093

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  16 in total

1.  Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.

Authors:  Ashwani Gupta; Faiz Subzposh; Shelley R Hankins; Steven P Kutalek
Journal:  Tex Heart Inst J       Date:  2015-04-01

2.  [Lead survival and complications (except infections). Are we doing better nowadays?].

Authors:  Martin Seifert; Michael Neuss; Maren Schöpp; Cornel Koban; Christian Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-06

3.  First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes.

Authors:  Giovanni B Forleo; Luigi Di Biase; Massimo Mantica; Germana Panattoni; Matteo Santamaria; Quintino Parisi; Domenico Sergi; Lida P Papavasileiou; Luca Santini; Claudio Tondo; Andrea Natale; Francesco Romeo
Journal:  J Interv Card Electrophysiol       Date:  2013-07-03       Impact factor: 1.900

4.  Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making.

Authors:  Milena Leo; Alexander J Sharp; Andre Briosa E Gala; Michael T B Pope; Timothy R Betts
Journal:  J Interv Card Electrophysiol       Date:  2022-07-14       Impact factor: 1.759

5.  Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

Authors:  Frederic S Resnic; Arjun Majithia; Sanket S Dhruva; Henry Ssemaganda; Susan Robbins; Danica Marinac-Dabic; Kathleen Hewitt; Lucila Ohno-Machado; Matthew R Reynolds; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-14

Review 6.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

7.  Biventricular pacing and coronary sinus ICD lead implantation in a patient with a mechanical tricuspid valve replacement.

Authors:  Neil T Srinivasan; Oliver R Segal
Journal:  J Cardiol Cases       Date:  2015-08-29

8.  Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy.

Authors:  G H van Welsenes; C J W Borleffs; J B van Rees; J Z Atary; J Thijssen; E E van der Wall; M J Schalij
Journal:  Neth Heart J       Date:  2010-12-22       Impact factor: 2.380

9.  Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands : An expert consensus report of the Netherlands Society of Cardiology.

Authors:  C C de Cock; J Elders; N M van Hemel; K van den Broek; L van Erven; B de Mol; J Talmon; D A M J Theuns; W de Voogt
Journal:  Neth Heart J       Date:  2012-02       Impact factor: 2.380

10.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems.

Authors:  Niraj Varma; Behzad B Pavri; Bruce Stambler; Justin Michalski
Journal:  Europace       Date:  2012-12-19       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.